Close Menu

NEW YORK – Laboratory automation firm Miroculus said on Thursday that it has completed a Series B financing extension bringing the total capital raised in the round to $45 million.

The financing round was led by Cota Capital with participation from Section 32. In conjunction with the investment, Bobby Yazdani, founder and partner of Cota Capital, will join Miroculus' board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.